Latest Advances in CAR T-Cell Therapy for Lymphomas and Multiple Myeloma

Decera Clinical Education Oncology Podcast · Sep 3, 2025 · 16m

In this episode, Dr Brad Kahl and Dr Noopur Raje discuss the recent advances and emerging data for CAR T-cell therapy in lymphomas and multiple myeloma including the latest evidence from long-term clinical trial follow-up and real-world data, plus new data with CAR T-cell therapies in new lymphoma settings and novel CAR T-cell therapies currently under development for multiple myeloma.

Lymphomas

DLBCL: Real-world outcomes post axi-cel, CAR T vs autologous HSCT

FL: Tisa-cel (ELARA), axi-cel (ZUMA-5)

MZL: Liso-cel (TRANSCEND FL)

MCL: Real-world outcomes post brexu-cel

CLL: Liso-cel (TRANSCEND…